Sulfuric Acid

Sulfuric Acid

SCHEMBL1618232

O.O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Ce+4].[NH4+].[NH4+]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL27201625 1.00 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL1902968 1.00 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL8088782 1.00 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL29804804 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL2541683 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL29903442 0.94
Sulfuric Acid SCHEMBL132414 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL8137878 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL25407166 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL29059842 0.94 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720573-A1 DECONTAMINATION COMPOSITIONS AND METHODS OF DECONTAMINATION Battelle Memorial Institute (US) 2020-10-14 EP claimed
CN-111655343-A Decontamination composition and decontamination method 巴特尔纪念研究院 2020-09-11 CN claimed
WO-2019112571-A1 DECONTAMINATION COMPOSITIONS AND METHODS OF DECONTAMINATION BATTELLE MEMORIAL INSTITUTE (US) 2019-06-13 WO claimed
WO-2015135176-A1 CATALYSTS, METHODS, AND SYSTEMS FOR PREPARING CARBAMATES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-09-17 WO claimed
CN-111655343-A Decontamination composition and decontamination method 巴特尔纪念研究院 2020-09-11 CN disclosed
US-10000448-B2 Catalysts, methods, and systems for preparing carbamates EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2018-06-19 US disclosed
US-20170015622-A1 CATALYSTS, METHODS, AND SYSTEMS FOR PREPARING CARBAMATES EMPIRE TECHNOLOGY DEVELOPMENT LLC 2017-01-19 US disclosed
EP-3092067-A1 METHOD OF PREPARING A CATALYST STRUCTURE Teknologisk Institut (DK) 2016-11-16 EP disclosed
US-9443713-B2 Oxidizing aqueous cleaner for the removal of post-etch residues ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2016-09-13 US disclosed
WO-2015135176-A1 CATALYSTS, METHODS, AND SYSTEMS FOR PREPARING CARBAMATES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-09-17 WO disclosed
US-20150175556-A1 DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-06-25 US disclosed
EP-2867213-A1 DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2015-05-06 EP disclosed
WO-2014203044-A1 DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2014-12-24 WO disclosed
US-8765654-B2 Oxidizing aqueous cleaner for the removal of post-etch residues ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2014-07-01 US disclosed
EP-2682389-A1 Dihydropyrimidin-2(1H)-ones and dihydropyrimidin-2(1H)-thiones as inhibitors of sodium iodide symporter COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2014-01-08 EP disclosed
US-20110186086-A1 OXIDIZING AQUEOUS CLEANER FOR THE REMOVAL OF POST-ETCH RESIDUES ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2011-08-04 US disclosed
US-7922824-B2 Oxidizing aqueous cleaner for the removal of post-etch residues ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2011-04-12 US disclosed
US-20090215658-A1 OXIDIZING AQUEOUS CLEANER FOR THE REMOVAL OF POST-ETCH RESIDUES ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2009-08-27 US disclosed
EP-1932174-A1 OXIDIZING AQUEOUS CLEANER FOR THE REMOVAL OF POST-ETCH RESIDUES ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2008-06-18 EP disclosed
WO-2007044446-A1 OXIDIZING AQUEOUS CLEANER FOR THE REMOVAL OF POST-ETCH RESIDUES ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175556-A1 DIHYDROPYRIMIDIN-2(1H)-ONES AND DIHYDROPYRIMIDIN-2(1H)-THIONES AS INHIBITORS OF SODIUM IODIDE SYMPORTER SLC40A1, SLC5A11, SLC20A1 MEN1 235/4885ALDH1A1 583/4885TSHR 166/4885
US-10000448-B2 Catalysts, methods, and systems for preparing carbamates CA7, CA3, SOD1 MEN1 891/4885ALDH1A1 3030/4885TSHR 525/4885
US-20170015622-A1 CATALYSTS, METHODS, AND SYSTEMS FOR PREPARING CARBAMATES CA7, CA3, SOD1 MEN1 891/4885ALDH1A1 3030/4885TSHR 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.